Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Recombinant tissue-type plasminogen activator and immediate angioplasty in acute myocardial infarction. One-year follow-up. The European Cooperative Study Group.
Alfred Arnold, M. L. Simoons, Frans Van de Werf, D P de Bono, Jacobus Lubsen, JG Tijssen, Patrick W. Serruys, M Verstraete (1992). Recombinant tissue-type plasminogen activator and immediate angioplasty in acute myocardial infarction. One-year follow-up. The European Cooperative Study Group.. Circulation, 86(1), pp. 111-120, DOI: 10.1161/01.cir.86.1.111.
Article393 days agoRecombinant tissue-type plasminogen activator and immediate angioplasty in acute myocardial infarction.
Alfred Arnold, Maarten Simoons, David de Bono, Jan Tijssen, Patrick W. Serruys, Marc Verstraete, J Lubsen, Frans Van de Werf (1992). Recombinant tissue-type plasminogen activator and immediate angioplasty in acute myocardial infarction.. , 86, pp. 111-120
Article393 days agoIn-hospital clinical course of patients without CK elevation following thrombolysis for ST elevation myocardial infarction: insights from the Assent-2 trial
Claudio Fresco, Aldo P. Maggioni, H. Willems, Giancarlo Agnelli, Emmanuel Lesaffre, Frans Van de Werf (2000). In-hospital clinical course of patients without CK elevation following thrombolysis for ST elevation myocardial infarction: insights from the Assent-2 trial. , 102(18)
Article323 days agoAre recurrent ischaemic events more common in patients with aborted myocardial infarction following thrombolytic therapy? Insights from 15869 patients from the Assent-2 trial
Claudio Fresco, Aldo P. Maggioni, H. Willems, Giancarlo Agnelli, Emmanuel Lesaffre, Frans Van de Werf (2000). Are recurrent ischaemic events more common in patients with aborted myocardial infarction following thrombolytic therapy? Insights from 15869 patients from the Assent-2 trial. , 21
Article323 days agoDespite geographical heterogeneity in baseline use, guideline-directed treatments for acute coronary syndromes improve in all regions from 1999 to 2003. The Global Registry of Acute Coronary Events
RH Mehta, Frans Van de Werf, Álvaro Avezum, Giancarlo Agnelli, KA Eagle, R.J. Goldberg, Omar Dabbous, CB Granger (2005). Despite geographical heterogeneity in baseline use, guideline-directed treatments for acute coronary syndromes improve in all regions from 1999 to 2003. The Global Registry of Acute Coronary Events. , 112(17)
Article323 days ago